19. Access to diagnosis and treatment of at the district level: Perspectivese from patients HCV/HIV co-infection

Vu Quoc Dat, Ta Thi Dieu Ngan, Nguyen Thi Thuy Van, Phan Thi Thu Huong, Do Thi Nhan, Dao Xuan Vinh, Nguyen Thi Huyen Trang

Main Article Content

Abstract

This study evaluated the advantages, disadvantages, and feasibility of accessing diagnosis and treatment of HCV in patients with HIV co-infection at the district level: perspectives from patients. A qualitative study was conducted with 19 in-depth interviews with service users in 5 provinces from June to December 2022. The results showed that integrated HCV and ARV treatment services at district health facilities allow patients to access many services simultaneously, reducing travel costs and saving time. The facilities at hepatitis C treatment centers were well appreciated by the patients, the examination and treatment process were clear, testing procedures were speedy, and the waiting time was short. 100% of patients had their condition improved after completing the hepatitis C treatment protocols. However, viral load was tested at upper-level hospitals, causing many difficulties for patients to approach treatment and complete the regimen. More than 50% of patients are willing to pay the co-payment for medication with Health Insurance.

Article Details

References

1. Flower B, Du Hong D, Kim HVT, et al. Seroprevalence of Hepatitis B, C and D in Vietnam: A systematic review and meta-analysis. The Lancet Regional Health-Western Pacific. 2022;24:100468.
2. Dao D MG, Pham LT, et al. EASL International Liver Fundation: The Vietnam Viral Hepatitis Alliance (V-VHA) dedicated to viral hepatitis initiatives in Vietnam. 2019.
3. Cục phòng chống HIV/AIDS, Bộ Y tế. Tăng cường điều trị đồng nhiễm Viêm gan C với HIV. 2022; https://vaac.gov.vn/tang-cuong-dieu-tri-dong-nhiem-viem-gan-c-voi-hiv.html.
4. QSR Q. NVivo qualitative data analysis software. Victoria, Australia: QSR International Pty Ltd. 2008.
5. Bộ Y tế. Các tỉnh thúc đẩy điều trị viêm gan C cho người bệnh đồng nhiễm HIV/VGC. 2022; https://moh.gov.vn/hoat-dong-cua-dia-phuong/-/asset_publisher/gHbla8vOQDuS/content/cac-tinh-thuc-ay-ieu-tri-viem-gan-c-cho-nguoi-benh-ong-nhiem-hiv-vgc.
6. Westbrook R, Dusheiko G. Natural history of hepatitis C. J Hepatol. 2014;61:S58-S68.
7. Boeke CE, Adesigbin C, Agwuocha C, et al. Initial success from a public health approach to hepatitis C testing, treatment and cure in seven countries: the road to elimination. BMJ Global Health. 2020;5(12):e003767.
8. Draper BL, Yee WL, Shilton S, et al. Feasibility of decentralised, task-shifted hepatitis C testing and treatment services in urban Myanmar: implications for scale-up. BMJ open. 2022;12(5):e059639.
9. Farmer T, Brook G, McSorley J, Murphy S, Mohamed A. Using short message service text reminders to reduce ‘did not attend’rates in sexual health and HIV appointment clinics. J International journal of STD AIDS. 2014;25(4):289-293.
10. McLean S, Gee M, Booth A, et al. Targeting the use of reminders and notifications for uptake by populations (TURNUP): a systematic review and evidence synthesis. J Health Services Delivery Research. 2014;2(34).
11. Markby J, Gupta E, Soni D, et al. Feasibility, effectiveness and cost of a decentralized HCV care model among the general population in Delhi, India. J Liver International. 2022;42(3):532-540.